Quaker Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Quaker Wealth Management's VRTX Position: Q2 2026 in Review
Quaker Wealth Management reduced its Vertex Pharmaceuticals (VRTX) stake by 86% in Q2 2026, selling an estimated $19.1K and leaving 7 shares worth $3.48K. The position accounts for ﹤0.01% of the portfolio, ranked #382.
Quaker Wealth Management first reported a position in VRTX in Q2 2025 and has held it in 5 quarters since. The position peaked at $22.3K in Q1 2026. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Quaker Wealth Management held 7 shares of Vertex Pharmaceuticals worth $3.48K as of Q2 2026.
- Quaker Wealth Management sold 43 Vertex Pharmaceuticals shares in Q2 2026, an estimated $19.1K.
- Vertex Pharmaceuticals made up ﹤0.01% of Quaker Wealth Management's portfolio in Q2 2026, its #382 holding.
- Quaker Wealth Management first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
- Quaker Wealth Management's Vertex Pharmaceuticals position peaked at $22.3K in Q1 2026.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.